Literature DB >> 17913278

Association of polymorphisms in the insulin-degrading enzyme gene with type 2 diabetes in the Korean population.

S H Kwak1, Y M Cho, M K Moon, J H Kim, B L Park, H S Cheong, H D Shin, H C Jang, S Y Kim, H K Lee, K S Park.   

Abstract

Insulin-degrading enzyme (IDE) is a metalloproteinase which degrades insulin and terminates its action. Homologous deletion of IDE gene resulted in hyperinsulinemia and glucose intolerance in a rat model of type 2 diabetes mellitus. Several genetic association studies examined IDE as a susceptibility gene for type 2 diabetes in European descents. Here we investigated the genetic association of IDE polymorphisms with the risk of type 2 diabetes and its related phenotypes in the Korean population. Among six single nucleotide polymorphisms analyzed, g.-179T>C (OR=1.73, P=0.04), and g.IVS18+99G>A (OR=1.23, P=0.02) revealed borderline association with increased risk of type 2 diabetes. Combining our results with previous data obtained from the European population, g.-179T>C (OR=1.11, P=0.03), and g.IVS24-64A>T (OR=1.18, P=0.005) showed significant association with type 2 diabetes. Haplotype consisting of common alleles of the six polymorphisms was associated with decreased risk of type 2 diabetes (OR=0.82, P=0.02). However, none of the polymorphisms was significantly associated with metabolic phenotypes. We can conclude that variations in IDE might contribute to diabetes susceptibility in the Korean population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17913278     DOI: 10.1016/j.diabres.2007.08.017

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  12 in total

1.  Postprandial Insulin Response and Clearance Among Black and White Women: The Federal Women's Study.

Authors:  Stephanie T Chung; Mirella Galvan-De La Cruz; Paola C Aldana; Lilian S Mabundo; Christopher W DuBose; Anthony U Onuzuruike; Mary Walter; Ahmed M Gharib; Amber B Courville; Arthur S Sherman; Anne E Sumner
Journal:  J Clin Endocrinol Metab       Date:  2019-01-01       Impact factor: 5.958

2.  Candidate genes for Alzheimer's disease are associated with individual differences in plasma levels of beta amyloid peptides in adults with Down syndrome.

Authors:  Nicole Schupf; Annie Lee; Naeun Park; Lam-Ha Dang; Deborah Pang; Alexander Yale; David Kyung-Taek Oh; Sharon J Krinsky-McHale; Edmund C Jenkins; José A Luchsinger; Warren B Zigman; Wayne Silverman; Benjamin Tycko; Sergey Kisselev; Lorraine Clark; Joseph H Lee
Journal:  Neurobiol Aging       Date:  2015-06-19       Impact factor: 4.673

3.  Expression of metalloprotease insulin-degrading enzyme insulysin in normal and malignant human tissues.

Authors:  Christina Yfanti; Karin Mengele; Apostolos Gkazepis; Gregor Weirich; Cecylia Giersig; Wen-Liang Kuo; Wei-Jen Tang; Marsha Rosner; Manfred Schmitt
Journal:  Int J Mol Med       Date:  2008-10       Impact factor: 4.101

4.  IDE (rs6583817) polymorphism and type 2 diabetes differentially modify executive function in older adults.

Authors:  G Peggy McFall; Sandra A Wiebe; David Vergote; David Westaway; Jack Jhamandas; Roger A Dixon
Journal:  Neurobiol Aging       Date:  2013-04-16       Impact factor: 4.673

5.  Glucose inhibits the insulin-induced activation of the insulin-degrading enzyme in HepG2 cells.

Authors:  O Pivovarova; O Gögebakan; A F H Pfeiffer; N Rudovich
Journal:  Diabetologia       Date:  2009-04-25       Impact factor: 10.122

6.  Crystal and solution structures of a prokaryotic M16B peptidase: an open and shut case.

Authors:  Alexander E Aleshin; Svetlana Gramatikova; Gregory L Hura; Andrey Bobkov; Alex Y Strongin; Boguslaw Stec; John A Tainer; Robert C Liddington; Jeffrey W Smith
Journal:  Structure       Date:  2009-11-11       Impact factor: 5.006

7.  Polymorphisms within insulin-degrading enzyme (IDE) gene determine insulin metabolism and risk of type 2 diabetes.

Authors:  Natalia Rudovich; Olga Pivovarova; Eva Fisher; Antje Fischer-Rosinsky; Joachim Spranger; Matthias Möhlig; Matthias B Schulze; Heiner Boeing; Andreas F H Pfeiffer
Journal:  J Mol Med (Berl)       Date:  2009-10-07       Impact factor: 4.599

Review 8.  Targeting Insulin-Degrading Enzyme in Insulin Clearance.

Authors:  Malcolm A Leissring; Carlos M González-Casimiro; Beatriz Merino; Caitlin N Suire; Germán Perdomo
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

9.  FitSNPs: highly differentially expressed genes are more likely to have variants associated with disease.

Authors:  Rong Chen; Alex A Morgan; Joel Dudley; Tarangini Deshpande; Li Li; Keiichi Kodama; Annie P Chiang; Atul J Butte
Journal:  Genome Biol       Date:  2008-12-05       Impact factor: 13.583

10.  Genetic associations of type 2 diabetes with islet amyloid polypeptide processing and degrading pathways in asian populations.

Authors:  Vincent Kwok Lim Lam; Ronald Ching Wan Ma; Heung Man Lee; Cheng Hu; Kyong Soo Park; Hiroto Furuta; Ying Wang; Claudia Ha Ting Tam; Xueling Sim; Daniel Peng-Keat Ng; Jianjun Liu; Tien-Yin Wong; E Shyong Tai; Andrew P Morris; Nelson Leung Sang Tang; Jean Woo; Ping Chung Leung; Alice Pik Shan Kong; Risa Ozaki; Wei Ping Jia; Hong Kyu Lee; Kishio Nanjo; Gang Xu; Maggie Chor Yin Ng; Wing-Yee So; Juliana Chung Ngor Chan
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.